Kelley Shannon T, General Counsel of Madrigal Pharmaceuticals ($MDGL), sold nearly $980,000 worth of company shares across 11 open market transactions in the last 365 days. Her most recent sale occurred on March 6, 2026. These sales rank her 4,986th among 11,678 individual insiders by total sold amount, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | A | Stock Option (Right to Buy) | 5022 | $0.00 | 5,022.0000 | 22,939,969 | 9999.99% | 0.02% |
| March 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 360 | $431.94 | 12,138.0000 | 22,939,969 | 2.88% | 0.00% |
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | A | Common Stock | 4017 | $0.00 | 12,498.0000 | 22,939,969 | 47.36% | 0.02% |
| Jan. 20, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 429 | $501.40 | 8,481.0000 | 22,711,420 | 4.81% | 0.00% |
| Jan. 20, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 263 | $490.77 | 8,910.0000 | 22,711,420 | 2.87% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 68 | $374.13 | 9,405.0000 | 22,080,246 | 0.72% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 190 | $375.75 | 9,215.0000 | 22,080,246 | 2.02% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 42 | $376.62 | 9,173.0000 | 22,080,246 | 0.46% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 458 | $358.66 | 10,019.0000 | 22,080,246 | 4.37% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 126 | $369.64 | 9,893.0000 | 22,080,246 | 1.26% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 84 | $370.06 | 9,809.0000 | 22,080,246 | 0.85% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 84 | $371.35 | 9,725.0000 | 22,080,246 | 0.86% | 0.00% |
| Aug. 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 252 | $372.44 | 9,473.0000 | 22,080,246 | 2.59% | 0.00% |
| March 5, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | A | Stock Option (Right to Buy) | 5368 | $0.00 | 5,368.0000 | 22,080,246 | 9999.99% | 0.02% |
| March 5, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | A | Common Stock | 3187 | $0.00 | 10,477.0000 | 22,080,246 | 43.72% | 0.01% |
| March 3, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 415 | $335.00 | 7,290.0000 | 22,080,246 | 5.39% | 0.00% |
| Jan. 17, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | S | Common Stock | 277 | $273.41 | 7,705.0000 | 0 | 3.47% | 0.00% |
| Aug. 15, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | A | Stock Option (Right to Buy) | 7820 | $0.00 | 7,820.0000 | 0 | 9999.99% | 0.00% |
| Aug. 15, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Kelley Shannon T | General Counsel | A | Common Stock | 5215 | $0.00 | 7,982.0000 | 0 | 188.47% | 0.00% |